| 2014 年热门生物技术公司的研发动态 |
| |
| 引用本文： | 劳兴珍,杨臻峥,邢爱敏,康银花,范鸣,郑晓南,顾觉奋.2014 年热门生物技术公司的研发动态[J].微生物学杂志,2014,38(11). |
| |
| 作者姓名： | 劳兴珍 杨臻峥 邢爱敏 康银花 范鸣 郑晓南 顾觉奋 |
| |
| 作者单位： | 中国药科大学生命科学与技术学院，江苏 南京 210009,中国药科大学《药学进展》编辑部，江苏 南京 210009,中国药科大学《药学进展》编辑部，江苏 南京 210010,中国药科大学《药学进展》编辑部，江苏 南京 210011,中国药科大学《药学进展》编辑部，江苏 南京 210012,中国药科大学《药学进展》编辑部，江苏 南京 210013,中国药科大学生命科学与技术学院，江苏 南京 210009 |
| |
| 摘 要： | FierceBiotech 网站报道了2014 年最热门的16 家生物技术公司，其涉足生物制药、体外诊断以及医疗器械研发等热门医疗领域，其中多家公司与包括葛兰素史克、罗氏、拜耳、默克等公司在内的制药巨头展开合作，值得医疗行业的投资者关注。对这16 家热门生物技术公司的研发重点、主打产品的适应证/ 用途、合作伙伴、并购交易信息进行归纳总结，旨在为新一代生物技术药物的深入研发提供参考。
|
| 关 键 词： | 生物制药 体外诊断 小分子免疫平台 基因剪切 抗体- 药物偶联疗法 |
Research and Development Trend of Top Biotech Companies in 2014 |
| |
| LAO Xingzhen,YANG Zhenzheng,XING Aimin,KANG Yinhu,FAN Ming,ZHENG Xiaonan and GU Juefen.Research and Development Trend of Top Biotech Companies in 2014[J].Journal of Microbiology,2014,38(11). |
| |
| Authors: | LAO Xingzhen YANG Zhenzheng XING Aimin KANG Yinhu FAN Ming ZHENG Xiaonan and GU Juefen |
| |
| Institution: | School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China,Editorial Office of Progress inPharmaceutical Sciences, China Pharmaceutical University, Nanjing 210009, China,School of Life Science and Technology, China Pharmaceutical University, Nanjing 210010, China,Editorial Office of Progress inPharmaceutical Sciences, China Pharmaceutical University, Nanjing 210010, China,School of Life Science and Technology, China Pharmaceutical University, Nanjing 210011, China,Editorial Office of Progress inPharmaceutical Sciences, China Pharmaceutical University, Nanjing 210011, China and School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China |
| |
| Abstract: | FierceBiotech has reported 16 most popular biotech companies of 2014, which were involved in biopharmaceuticals, in vitro diagnostic,medical devices R&D, etc. Several companies were worth paying attention by medical industry investors, because they took cooperative projects with pharmaceutical giant including GlaxoSmithKline, Roche, Bayer, Merck, etc. The research and development trend of 16 most popular biotech companies of 2014 has been summarized and introduced in this paper, including their main products, indications/uses of these products, cooperative partners and information of related deals, so as to provide references for the further development of the novel biotech drugs. |
| |
| Keywords: | biopharmaceuticals in vitro diagnostic small molecular immune system gene splicing antibody-drug conjugate therapy |
|
| 点击此处可从《微生物学杂志》浏览原始摘要信息 |
| 点击此处可从《微生物学杂志》下载免费的PDF全文 |
|
